Case report
4
/l. Cell markers of leukemic cells were CD10
+ , CD19 + , CD34
+ , HLA-DR + . Cytogenetic identical sibling. This is the first report of DLI use before the onset of hematological relapse monitored by analysis and RT-PCR revealed this patient had 46,XX,t(9;22)(q23;q11) with minor BCR-ABL chimeric the results of RT-PCR. This patient has been in CR for 11 months after BMT, suggesting this alternative treatmRNA. She had entered CR after induction therapy and was to receive BMT in first CR from an HLA-identical ment is promising for Ph ؉ ALL with positive reverse transcriptase-polymerase chain reaction (RT-PCR)
brother. She developed acute pancreatitis due to l-asparaginase, delaying the BMT schedule by 14 days. BM aspirfollowing BMT. Keywords: acute lymphoblastic leukemia; bone marrow ation just before conditioning contained 5% leukemic cells and fluorescence in situ hybridization (FISH) analysis using transplantation; donor leukocyte infusion; Philadelphia chromosome; reverse transcriptase-polymerase chain reaca BCR-ABL-specific probe was positive. Conditioning was with busulfan 4 mg/kg/day on days −7 and −6; melphalan tion 70 mg/m 2 /day on days −5, −4 and −3; TBI 3 Gy × 2 on days −2 and −1. The total number of nucleated cells harvested from the donor was 3.4 × 10 8 /kg of recipient body The prognosis of Philadelphia chromosome-positive acute weight. GVHD prophylaxis consisted of MTX 15 mg/m 2 lymphoblastic leukemia (Ph + ALL) is very poor. 1 Bone on day +1, 10 mg/m 2 on days +3, +6, +11, and once a week marrow transplantation (BMT) is the most effective thereafter. The patient engrafted normally (neutrophils modality of treatment for Ph + ALL. Nevertheless, recur-Ͼ0.5 × 10 9 /l on day +16, platelets Ͼ20 × 10 9 /l on day +21). rence of original disease remains one of the major obstacles No GVHD developed until day +32. RT-PCR was perforin the treatment of Ph + ALL. 2-5 Donor leukocyte infusion med using primers to detect BCR-ABL chimeric mRNA. (DLI) is a promising modality for patients relapsing after Briefly, total cellular RNA was isolated according to the BMT.
6-11 The efficacy of DLI for ALL patients relapsing guanidine isothiocyanate phenol/chloroform method. PCR after BMT has been less effective, 9,10 although there have was performed by the nested PCR using two oligonucleobeen several reports that DLI was effective for relapsing tide primers, 5′-CGCTCTCCCTCGCAGAACTC-3′ and 5′-CML patients after BMT. [6] [7] [8] GGCCCATGGTACCAGGAGTG-3′ for the first step and Reverse transcriptase-polymerase chain reaction (RT-5′-CGCATGTTCCGGGACAAAAGC-3′ and 5′-GTTTCT-PCR) is a very sensitive method for detecting minimal CCAGACTGTTGACTG-3′ for the second step. PCR conresidual disease (MRD) in Ph + ALL. Miyamura et al 12 ditions consisted of 60 s at 94°C, 60 s at 65°C and 90 s at reported that patients with Ph + ALL who received BMT 72°C for 35 cycles at each step. Amplified PCR products would relapse within 3-9 weeks if the RT-PCR became were separated by electrophoresis on 2% Nu Sieve GTG positive after BMT.
agarose and 1% agarose gels. If two independent We report a case of Ph + ALL, where the RT-PCR researchers got different results, an additional four tests remained positive after BMT, who successfully received were performed. RT-PCR were checked on days +14, +21, DLI before the onset of hematological relapse.
+35 after BMT with positive results, suggesting a high risk of relapse (Table 1) . 12 RT-PCR was still positive on day +54 without GVHD, although MTX for GVHD prophylaxis BMT. 
